Desjardins Issues Pessimistic Forecast for Evogene (TSE:EVGN) Stock Price
Evogene (TSE:EVGN – Free Report) had its price objective reduced by Desjardins from C$4.00 to C$3.00 in a research note published on Tuesday,BayStreet.CA reports. They currently have a buy rating on the stock. Separately, Ventum Financial reduced their price objective on shares of Evogene from C$4.00 to C$3.00 in a research note on Friday, November […]
